Gulf International Bank UK Ltd Sells 99 Shares of Humana Inc. (NYSE:HUM)

Gulf International Bank UK Ltd cut its holdings in Humana Inc. (NYSE:HUM) by 1.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,767 shares of the insurance provider’s stock after selling 99 shares during the period. Gulf International Bank UK Ltd’s holdings in Humana were worth $2,477,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the business. Pinnacle Wealth Management Advisory Group LLC raised its position in Humana by 3.6% in the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider’s stock worth $272,000 after acquiring an additional 37 shares during the period. Atlas Brown Inc. raised its position in Humana by 0.6% in the fourth quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider’s stock worth $1,611,000 after acquiring an additional 38 shares during the period. Moors & Cabot Inc. raised its position in Humana by 2.5% in the third quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock worth $519,000 after acquiring an additional 40 shares during the period. Mather Group LLC. increased its stake in shares of Humana by 21.0% in the fourth quarter. Mather Group LLC. now owns 236 shares of the insurance provider’s stock worth $60,000 after purchasing an additional 41 shares in the last quarter. Finally, Capital Advisors Ltd. LLC increased its stake in shares of Humana by 26.1% in the fourth quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider’s stock worth $53,000 after purchasing an additional 43 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Insider Transactions at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares in the company, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.32% of the company’s stock.

Analysts Set New Price Targets

HUM has been the subject of a number of analyst reports. Barclays increased their price objective on shares of Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 13th. Royal Bank of Canada reissued an “outperform” rating and issued a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Truist Financial increased their price objective on shares of Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research note on Monday, January 6th. Bank of America raised shares of Humana from an “underperform” rating to a “neutral” rating and increased their price objective for the stock from $247.00 to $308.00 in a research note on Wednesday, November 6th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research note on Tuesday, February 18th. Nineteen research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $285.68.

Humana Stock Performance

Shares of NYSE:HUM opened at $270.91 on Friday. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The stock has a market capitalization of $32.68 billion, a P/E ratio of 27.23, a PEG ratio of 2.05 and a beta of 0.56. The firm has a fifty day simple moving average of $271.11 and a two-hundred day simple moving average of $287.34. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.31%. Humana’s dividend payout ratio (DPR) is presently 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.